A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Audited Results of Q-Line Biotech Ltd. Company
| (Rs in Cr.) | Mar 31, 2023 |
| Operating Income | 183.09 |
| Manufacturing Expenses | 0 |
| Personnel Expenses | 22.91 |
| Selling Expenses | 0 |
| Administrative Expenses | 29.73 |
| Expenses Capitalised | 0 |
| Cost Of Sales | 146.63 |
| Operating Profit | 36.46 |
| Other Recurring Income | 2.38 |
| Adjusted PBDIT | 38.84 |
| Financial Expenses | 4.48 |
| Depreciation | 1.81 |
| Other Write offs | 0 |
| Adjusted PBT | 32.55 |
| Tax Charges | 8.38 |
| Adjusted PAT | 24.17 |
| Non Recurring Items | 0 |
| Other Non Cash adjustments | 0 |
| Reported Net Profit | 24.17 |
| Equity Dividend | 0 |
| Preference Dividend | 0 |
| Retained Earnings | 116.75 |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
More Information on Q-Line Biotech Ltd.
-
Q-Line Biotech Ltd. Company Details
- Company Profile
- Company History
- Management Team
- Banker/Auditor/Registrar
-
Q-Line Biotech Ltd. Key Financial Ratios
- Ratios
-
Q-Line Biotech Ltd. Financial Data
- Audited Results
- Cash Flow
- Balance Sheet
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+